RNA5SP315

Across TCGA pan-cancer cohorts, RNA5SP315 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNA5SP315 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNA5SP315 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP315 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

LUSC, LAML, and STAD are the cancer types where RNA5SP315 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	III,IV	0.001	0.684	<.001	72	view →
LAML	DFS	Tertile	All	0.684	0.518	.016	20	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNA5SP315–LUSC (OS)

Open the LUSC breakdown →